Agalsidase beta Terminated Phase 2 Trials for Fabry's Disease / Chronic Kidney Disease, Stage IV (Severe) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00837824Severe Renal Disease Study in Fabry Patients Treated With Fabrazyme